echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Confirm! The new crown vaccine in China is beginning to be vaccinated.

    Confirm! The new crown vaccine in China is beginning to be vaccinated.

    • Last Update: 2020-09-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: At present, China's bio-new corona inactivated vaccine international clinical (PHASE III. phase) into the group of more than 20,000 people, good safety.
    . First, the number of inoculations has exceeded 20,000 on August 23, Seber Blue Devices (ID:medchina) confirmed from authoritative sources, a number of domestic enterprises have issued a notice to organize employees to voluntarily vaccinate against the new coronal pneumonia vaccine, has begun to organize the list of vaccinated personnel, will be in batches of vaccination.
    , in principle, some people will be given priority, including planning to work overseas employees, frequent business travelers, marketing staff and so on.
    Zheng Zhongwei, director of the Science and Technology Development Center of the National Health And Health Commission and head of the special working group on vaccine research and development of the Joint Prevention and Control Mechanism of the State Council, revealed that China had officially launched the emergency use of the new crown vaccine on July 22.
    Today, according to CCTV news reports, China's bio-new corona inactivated vaccine international clinical (PHASE III. phase) into the group of more than 20,000 people, good safety, effectiveness in further observation, the speed of entry is better than expected, it is very worth looking forward to.
    (Screenshot Source: CCTV News) China's Vaccine Management Law stipulates that when a particularly major public health event occurs, the vaccine may be used urgently within a certain range and within a certain time frame, with the aim of establishing an immune barrier in special populations such as medical personnel, epidemic prevention personnel, border inspectors and those who guarantee the basic operation of the city.
    do you feel about people who have been vaccinated? According to the Observer Network reported on the 22nd, a female subject who has participated in the vaccine phase III vaccination trial said that the whole process of the trial did not have a special discomfort, only the first night of vaccination will feel a little hot, the next day is normal.
    party said that, to her knowledge, the first voluntary vaccination units were relative to the number of employees are not so many units, or because the enterprise has overseas assets and projects in operation, people need to enter and leave the affected areas.
    " will take blood pressure before vaccination, there is no very special physical examination program.
    but both groups are explicitly unable to participate in vaccinations, under the age of 18 and pregnant women," she added.
    II, good safety, no obvious adverse reactions it is known that China Pharmaceutical Group China Bio has two new corona inactivated vaccines, two vaccines I./II. phase clinical studies into the group of 2240 people, June 16 and 28, respectively, blind, the results show that the safety of vaccination is good, no obvious adverse reactions;
    two new crown inactivated vaccines are across the world in terms of safety, activation and other products.
    recently, Liu Jingxuan, party secretary and chairman of the State Pharmaceutical Group, said in an interview with the media:
    In my interview with the media, I have two injections of the new coronary pneumonia vaccine, there are no adverse reactions."
    " Liu Jingxuan also revealed that a dose of vaccine is 4 micrograms, a shot of vaccine, the protection rate is about 97%, two injections of vaccine, protection rate can reach 100%, the new crown inactivated vaccine on the market, the price is expected to be hundreds of dollars a shot.
    WHO, 139 of the 165 new crown vaccines currently being developed on WHO's official register are in the early stages of development and 26 are in clinical testing, according to WHO.
    six vaccines have entered Phase III clinical trials, three of which are from China.
    experts said that for vaccine research and development, China has always adhered to the virus inactivated vaccine, nucleic acid vaccine, recombinant protein vaccine, adenovirus vector vaccine, anti-virus virus vector vaccine five technical routes in parallel, each of the five routes have advantages and disadvantages complement each other, can improve the efficiency of vaccine research and development. according to
    , China National Pharmaceutical Group China Biologicals in Beijing and Wuhan, two biological products research institutes have built a high-grade biological safety production facilities, the two institutes of the production workshop put into use, China Bio will be able to ensure that the new crown vaccine annual production capacity of a total of 220 million doses.
    III, Wu Zunyou: Vaccines can effectively control the epidemic August 22, CCTV "dialogue" column again focused on the new crown vaccine, the State Council joint prevention and control mechanism research and development team vaccine research and development team, including Yang Xiaoming researchers, including relevant experts, guest "dialogue."
    In this program, the National Health and Health Commission Science and Technology Development Center Director, the State Council joint prevention and control mechanism of scientific research team vaccine research and development team leader Zheng Zhongwei revealed that the next step in order to prevent the outbreak in autumn and winter, will also consider a moderate expansion of the scope of emergency use of the new crown vaccine.
    on the adequacy of capacity for the new crown vaccine, Mr Zheng said China's annual biological capacity, combined with that of other companies, was expected to be guaranteed by the end of the year, in addition to clinical trials.
    For the future market pricing of the new crown vaccine, Zheng Zhongwei revealed that the new crown vaccine belongs to public health products, its pricing can not be based on the contradiction between supply and demand in the market, can only be based on cost pricing, "not that enterprises can not have profits, but to cost to approve your moderate profits or reasonable profits, this is the first principle in the future."
    of August, according to the State Pharmaceutical Group China Bio disclosure, Beijing Institute of Biological Products new crown inactivated vaccine production workshop has passed the state-related departments organized by the joint biosecurity inspection, with the conditions for use.
    , the production facility has just obtained a new crown vaccine production license.
    beijing's high-grade biosecurity facility, which has passed inspections, is the world's first and largest production plant for new crown inactivated vaccines.
    beijing Institute of Biological Products in just 2 months, on April 15 completed the construction of the workshop, creating a new crown inactivated vaccine workshop construction of the "Fire God Mountain" speed.
    mid-July, experts from relevant state departments conducted a comprehensive inspection of the biosecurity of the new crown vaccine production workshop of the Beijing Institute of Biological Products, which was considered to have basically met the requirements of the relevant national standards and could be put into mass production of the new crown vaccine.
    In response to many problems with the new crown vaccine, Wu Zunyou, chief epidemiologist at the China Center for Disease Control and Prevention, said that human infection with different viruses produces immunity for a different persistence, some will have a lifelong protective effect, and some produce very limited immunity.
    there are no definitive results on the immunity of new coronavirus, but observations of immunity to other coronavirus viruses are generally maintained for 6 to 12 months.
    as long as the vaccine has a protective effect, even 6 to 12 months, it is very important, it can effectively control the outbreak, the epidemic peak pressure down.
    with the new crown vaccine, it is possible to suppress the peak, so that the number of cases is controlled, which is particularly helpful to control the outbreak.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.